Here are relevant reports on : Pharmaceutical-Drug Delivery Market
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
The global pharmaceutical drug delivery market, valued at US$1,831.1B in 2023, is forecasted to grow at a 5.5% CAGR, reaching US$1,949.4B by 2024 and US$2,546.0B by 2029. The increasing patient population with chronic diseases, coupled with the growing geriatric population, rising technological advancements in pharmaceutical drug delivery products offering enhanced patient convenience and compliance, the growing adoption of home-based and self-administration, rising government initiatives promoting accessibility to pharmaceutical drug delivery, and the increasing demand for biosimilars and biologics are likely to support market growth.
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Medical Membranes Market by material (PTFE, PVDF, PP, PSU & PESU), Process Technology (UF, MF, NF), Application (Pharmaceutical Filtration, Hemodialysis, Drug Delivery, IV Infusion & Sterile Filtration), and Region-Global forecast to 2022
The medical membranes market is projected to grow from USD 2.13 Billion in 2017 to USD 3.31 Billion by 2022, at a CAGR of 9.2% during the forecast period. Medical membranes are increasingly used in the healthcare, pharmaceutical, biotechnology, and life sciences industries. In the medical sector, the choice of membranes depends on various factors that include environments of the proposed application, degree of sterility required, chemical compatibility, biocompatibility, and the degree of hydrophobicity.Pall Corporation (US), Asahi Kasei (Japan), 3M (US), Sartorius (Germany), and Merck Millipore (US) are key companies operating in the medical membranes market. Other major manufacturers of medical membranes include GE Healthcare (US), Koch Membrane Systems (US), and W. L. Gore & Associates (US).
- Published: June 2018
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled Syringes), Drug Delivery, and Region - Global Forecast to 2028
The pharmaceutical packaging market is expected to grow from USD 132.0 billion in 2023 to USD 269.9 billion by 2028, at a CAGR of 15.4% during the forecast period. Berry Global Group, Inc. (US), Gerresheimer AG (Germany), Amcor Plc (Switzerland), Schott AG (Germany), and AptarGroup, Inc. (US) are some major players in the pharmaceutical packaging market. These players have adopted various strategies such as mergers & acquisitions, joint ventures, and expansion to strengthen their market position.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Adhesive for Drug Delivery System Market by Resin Type, Technology and Geography - Global Forecast to 2019
This study estimates the global adhesive for drug delivery system for 2013 and projects the expected demand of the same by 2019. This market research study provides a detailed qualitative and quantitative analysis of the global adhesive for drug delivery system. It also includes a comprehensive review of major market drivers, restraints, opportunities, winning imperatives, challenges, and key issues in the market. The market is further segmented and forecast based by major regions North America, Europe, Asia-Pacific and RoW (Rest of the World). Market size for major countries of each region in terms of volume and value are covered.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Top 10 Drug Delivery Technologies Market (Topical, Oral Time Release/Sustained Release, Targeted Delivery, Encapsulation, Aerosol/Inhalation, Transdermal, Implants, Injectable, Liposomal, Pegylation) - Global Trends, Challenges & Forecasts up till 2015
This report provides industry analysis, competitive landscape and in-depth market segmentation for all the top 10 drug delivery technologies. It provides market data for the oral delivery system, which still dominates the drug delivery market. In addition, the report also analyzes the market data on emerging drug delivery technologies like needleless injectables, PEGylation technologies and microelectromechanical devices.
- Published: February 2011
- Price: $ 4950
- TOC Available:
-
European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017
The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.
- Published: June 2013
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Contract Manufacturing Market by Service (Drug Development, Pharmaceutical (API, FDF - Parenteral, Tablet, Capsule, Oral Liquid), Biologics (API, FDF), Packaging & Labelling, Fill-finish), End Users - Global Forecasts to 2029
The global pharmaceutical contract manufacturing market, valued at US$183.6B in 2023, is forecasted to grow at a 9.7% CAGR, reaching US$200.9B by 2024 and US$319.6B by 2029. Increasing use of generic drugs and funding, developments in the field of CMOs technology, the high cost of in-house drug discovery, and regulatory filing by the CMOs drive the growth of this market.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Global Albumin Market, by Product (Human Serum Albumin, Bovine Albumin, Recombinant Serum Albumin) by Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient) by Region - Forecast to 2022
The global albumin market is projected to grow at a CAGR of around 6% during the forecast period (2017-2022). Factors such as the high demand of albumin in R&D activities, rising non-therapeutic application of albumin, development of plant based albumin, rising production of immunoglobulins, and rise in plasma collection are driving the market. However, the stringent regulations, limited reimbursement, and irrational uses and adverse effects associated with albumin are the factors restraining the growth of this market.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Transdermal Drug Delivery System Market by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User, and Region - Global Forecast to 2023
The transdermal drug delivery system market is projected to reach USD 7.1 billion by 2023, growing at a CAGR of 4.5%. The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems. The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).
- Published: January 2019
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
